OCT 14, 2019 2:21 PM PDT

Injectable Drug reverses symptoms of liver disease in people with HIV

WRITTEN BY: Nouran Amin

In a study conducted by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute, scientists report that an injectable hormone ‘tesamorelin’ works to reduce liver fat and prevent liver fibrosis (scarring) in HIV patients with non-alcoholic fatty liver disease, or NAFLD.

National Institute of Allergy and Infectious Disease: A microscopic image of liver tissue affected by non-alcoholic fatty liver disease (NAFLD). The large and small white spots are excess fat droplets filling liver cells (hepatocytes). Credit: Dr. David Kleiner, NCI

"Many people living with HIV have overcome significant obstacles to live longer, healthier lives, though many still experience liver disease," said NIAID Director Anthony S. Fauci, M.D. "It is encouraging that tesamorelin, a drug already approved to treat other complications of HIV, may be effective in addressing non-alcoholic fatty liver disease."

Learn more about non-alcoholic fatty liver disease, or NAFLD:

 

 

"Our hope is that this intervention may help people living with HIV, as well as benefit HIV-negative people with liver abnormalities," said Dr. Hadigan. "Further research may inform us of the potential long-term benefits of this approach and develop formulations that can benefit everyone with liver disease, regardless of HIV status."

Tesamorelin, also known as Egrifta, was approved by the U.S. Food and Drug Administration in 2010 and works to reduce excess fat around the abdomen. Findings were published in The Lancet HIV.

"Because tesamorelin proved effective in treating abnormal fat build-up in the abdomens of people in the context of HIV and related medication use, we hypothesized that the drug might also reduce fat that accrues in the liver and causes damage in a similar population," said Steven K. Grinspoon, M.D., Chief of the Metabolism Unit at MGH.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 14, 2022
Health & Medicine
CBD and THC are Safe Supplements to Opioid Treatment
APR 14, 2022
CBD and THC are Safe Supplements to Opioid Treatment
A recent study found that it is safe and effective to use cannabidiol (CBD),∆9-tetrahydrocannabinol (THC), and CBD/THC m ...
APR 21, 2022
Health & Medicine
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
APR 21, 2022
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
Weill Cornell Medicine researchers recently discovered that inhibiting a key signaling pathway in brain cells can lessen ...
APR 21, 2022
Clinical & Molecular DX
An Emerging Need to Diagnose Maladaptive Daydreaming
APR 21, 2022
An Emerging Need to Diagnose Maladaptive Daydreaming
Maladaptive daydreaming (MD), also called daydreaming disorder, occurs in people who experience intense daydreams o ...
JUN 07, 2022
Health & Medicine
Drug that lowers blood sugar also reduces blood vessel dysfunction caused by aging
JUN 07, 2022
Drug that lowers blood sugar also reduces blood vessel dysfunction caused by aging
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives ...
JUN 15, 2022
Drug Discovery & Development
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
JUN 15, 2022
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
High-intensity-focused ultrasound (HIFU) can treat some men with prostate cancer instead of surgery or radiation therapy ...
JUN 19, 2022
Drug Discovery & Development
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
JUN 19, 2022
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
Researchers created a mathematical model that can predict drug combinations that may one day help treat heart attacks. T ...
Loading Comments...